EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Beyond integration: towards benchmarks for developmental potential in human stem cell-derived embryo models

Dorian G Luijkx iD, Leila Ashtar iD, Nienke de Graeff iD, Edith Coonen iD, Stefan Giselbrecht iD, Guido M W R de Wert iD, Erik J Vrij iD, Rhiannon Grant iD, Ana M Pereira Daoud iD

Human Reproduction Update · 01.05.2026 · 32 (3) · 313-332

DOI: 10.1093/humupd/dmaf033 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Human Reproduction Update, online erschienen am 05.01.2026. Verfasst von Dorian G Luijkx und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department for Cell Biology-Inspired Tissue Engineering, MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Maastr…. Hauptthemen laut MEDLINE: Embryonic Development, Embryo, Mammalian, Pluripotent Stem Cells, Models, Biological. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HipGametes consortium, Dutch Organization for Health Research and Development, GREAT consortium.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Stem cell-based embryo models (SCBEMs) are clusters of pluripotent stem cells that can mimic morphological and functional aspects of early human embryos to different degrees. When cultured from human cells, SCBEMs offer technically scalable and amenable tools that can help refine, reduce, and, in the future, perhaps replace the use of animals and human embryos in fundamental and clinical research. These advantages propelled the development of SCBEMs, and several distinct types have been generated over the past decade, including gastruloids, axioloids, blastoids, and post-implantation-like embryoids. For purposes of governance, advisory reports distinguish between SCBEMs based on their presumed capacity to continuously undergo organized human development—referred to here as developmental potential. However, since functionally testing this potential by transferring human SCBEMs to a uterus would be unethical and is recommended to be prohibited, scientists lack clear or consistent ways to assess it. OBJECTIVE AND RATIONALE This narrative review aims to tackle the question of how to assess developmental potential in SCBEMs by clarifying the different ways in which it can be and is being conceptualized. We achieve this by synthesizing insights from governance, science, and ethics. First, we examine how developmental potential is described in contemporary governance frameworks, and which aspects are emphasized. Next, we discuss biological markers for developmental potential and show how their scientific basis (in embryos, let alone SCBEMs) remains poorly understood. Then, we explore how the aspects considered relevant for assessments of developmental potential in governance and science may pre-emptively hinge on underlying conceptual interpretations and lead to differing normative implications. SEARCH METHODS This narrative review combines insights from both the academic and grey literature on the (ethics of) embryo models. Original and review articles were selected from PubMed and Biorxiv with the main focus on articles published since 2015. Search terms included: embryo quality, in vitro fertilization, Gardner system, blastoid, gastruloid, embryo research, potentiality argument, developmental potential, transcriptomics, epigenetics, embryo metabolism, and related terms. Additional sources were identified through snowballing. This work focuses predominantly on human SCBEMs, but references to animal models are made. OUTCOMES Comparison of the descriptions currently recommended for governance suggests at least three criteria that are used to assess developmental potential in SCBEMs: composition, organization, and interaction. Scientifically, developmental potential is multifaceted and only partly characterized, making it necessary to measure a broader range of aspects, using human embryos as benchmarks when possible. Since the range and significance of these aspects can be shaped by underlying accounts of developmental potential, contemporary advisory reports are examined to explore if and how they connote interpretations of developmental potential as possibility, probability, and predisposition. WIDER IMPLICATIONS Categorization of the regulatory and scientific criteria currently used to assess developmental potential shows that they are underpinned by distinct interpretations of the concept, revealing tensions and questions for further inquiry. By synthesizing insights from governance, science, and ethics, this review thus aims to contribute to the responsible advancement of the SCBEM field and to support its coherent and transparent governance. REGISTRATION NUMBER N/A.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Embryonic DevelopmentEmbryo, MammalianPluripotent Stem CellsModels, BiologicalHumansBenchmarking

Stichwörter der Autor:innen

benchmarksdevelopmental potentialethicsgovernancehuman stem cell-based embryo modelsintegrationscience

Autor:innen und Institutionen

  • Department for Cell Biology-Inspired Tissue Engineering, MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Maastricht, The Netherlands.
  • Department of Medical Ethics and Health Law, Leiden University Medical Center, Leiden, The Netherlands.
  • The Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW), Leiden Node, Leiden, The Netherlands.
  • Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Department of Obstetrics & Gynecology, GROW Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.
  • Department of Reproductive Medicine, Maastricht University Medical Center+, Maastricht, The Netherlands.

ORCID-Profile: Dorian G Luijkx, Leila Ashtar, Nienke de Graeff, Edith Coonen, Stefan Giselbrecht, Guido M W R de Wert, Erik J Vrij, Rhiannon Grant, Ana M Pereira Daoud

Förderung

  • HipGametes consortium
  • Dutch Organization for Health Research and Development
  • GREAT consortium
  • reNEW
  • Novo Nordisk Foundation Center for Stem Cell Medicine
  • Stichting De Weijerhorst
  • ZonMw

Zitieren

APA

Luijkx, D. G., Ashtar, L., de Graeff, N., Coonen, E., Giselbrecht, S., de Wert, G. M. W. R., Vrij, E. J., Grant, R., & Pereira Daoud, A. M. (2026). Beyond integration: towards benchmarks for developmental potential in human stem cell-derived embryo models. Human Reproduction Update, 32(3), 313-332. https://doi.org/10.1093/humupd/dmaf033

Vancouver

Luijkx DG, Ashtar L, de Graeff N, Coonen E, Giselbrecht S, de Wert GMWR, et al. Beyond integration: towards benchmarks for developmental potential in human stem cell-derived embryo models. Human Reproduction Update. 2026;32(3):313-332. doi:10.1093/humupd/dmaf033

BibTeX
@article{Luijkx2026,
  author = {Luijkx, Dorian G and Ashtar, Leila and de Graeff, Nienke and Coonen, Edith and Giselbrecht, Stefan and de Wert, Guido M W R and Vrij, Erik J and Grant, Rhiannon and Pereira Daoud, Ana M},
  title = {Beyond integration: towards benchmarks for developmental potential in human stem cell-derived embryo models},
  journal = {Human Reproduction Update},
  year = {2026},
  volume = {32},
  number = {3},
  pages = {313--332},
  doi = {10.1093/humupd/dmaf033}
}
Kostenlos starten →